Literature DB >> 2466973

Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342.

M E Fallowfield1.   

Abstract

The vasculature of B16, a murine melanoma and Mel-mo, a human melanoma, was studied using intravital staining of patent capillaries by the fluorescent bisbenzamine dye Hoechst 33342. Capillaries were numerous at the edge of tumours in both the lines studied, but were scarcer within the nodules. Vascular volume as a proportion of total tumour volume was estimated by means of point counting. In both B16 and Mel-mo, the percentage vascular volume was inversely related to log tumour weight. Tumour necrosis, which increased with tumour size, was inversely correlated with percentage vascular volume, emphasizing the central under-perfusion of these experimental tumour nodules. This pattern of perfusion, with greater density of functioning capillaries at the periphery of tumour nodules, was seen in both the tumour lines examined despite differences in the degree and pattern of necrosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466973     DOI: 10.1002/path.1711570312

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

1.  Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.

Authors:  A Bogdanov; E Marecos; H C Cheng; L Chandrasekaran; H C Krutzsch; D D Roberts; R Weissleder
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.

Authors:  M J Trotter; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

Review 3.  A review of the development of tumor vasculature and its effects on the tumor microenvironment.

Authors:  Jake C Forster; Wendy M Harriss-Phillips; Michael Jj Douglass; Eva Bezak
Journal:  Hypoxia (Auckl)       Date:  2017-04-11

4.  Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site Barrier.

Authors:  Brandon M Bordeau; Lubna Abuqayyas; Toan D Nguyen; Ping Chen; Joseph P Balthasar
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.